Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
NIH HHS News Release Logo
National Institute of Allergy and
Infectious Diseases (NIAID)

Monday, March 3, 2014

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

International Scientists Convene to Chart Path, Measure Progress Toward Global Vaccine Research and Development

Leading scientists, vaccine developers and public health officials from more than 40 countries will gather March 4-6, 2014, at the Global Vaccine and Immunization Research Forum in Bethesda, Md., to set priorities and assess progress in research and development for vaccines to prevent diseases that threaten public health worldwide. The forum is a step toward advancing the Global Vaccine Action Plan, a roadmap endorsed by the World Health Assembly in 2012 for preventing millions of deaths by 2020 by providing equitable access to existing vaccines for people in all communities and developing and introducing new and improved vaccines and technologies.
The meeting will include discussions on the current state of vaccine development for some of the world’s biggest killers, including HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases, as well as the development of a universal flu vaccine capable of protecting against all influenza strains. Other topics include regulatory issues and public health challenges associated with vaccines with modest efficacy, the benefits and risks of maternal vaccination, and research to improve monitoring and evaluation of immunization programs. By the close of the forum, scientists will identify the key steps and milestones necessary for making progress toward the stated goals of the Global Vaccine Action Plan.
The World Health Organization (WHO), the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Bill & Melinda Gates Foundation are co-hosting the meeting, and leaders from each organization will be presenting a keynote lecture on each day of the conference (see details below).
March 4-6, 2014, at the Hyatt Regency in Bethesda, Md.
NIAID Director Anthony S. Fauci, M.D. will present the opening keynote lecture on Tuesday, March 4, at 8:45 a.m., titled, “Vaccine Research and Development: Challenges and Opportunities.”
WHO Director-General Margaret Chan, M.D., will present the keynote lecture, “Research for Universal Health Coverage,” on Wednesday, March 5, at 8:30 a.m.
Bill & Melinda Gates Foundation Global Health President Trevor Mundel, M.D., Ph.D. will present the plenary lecture, “The Importance of Innovation in Addressing Global Health Gaps in the Developing World,” on Thursday, March 6, at 8:30 a.m.
The meeting’s agenda also is available.
For interviews, please contact Kathy Stover, NIAID, at (301) 402-1663 or

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH...Turning Discovery Into Health ®

back to top

Last Updated March 03, 2014

Last Reviewed March 02, 2014